Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pharmacovigilance And Drug Safety Software Market Size Forecast: How Big Could The Market Get By 2030?
The pharmacovigilance and drug safety software market has experienced substantial expansion in recent times. This market is projected to expand from $2.53 billion in 2025 to $2.86 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to its historical growth include a rise in adverse drug reaction reporting, the global expansion of clinical trials, stricter drug safety regulations, an increase in pharmaceutical manufacturing, and escalating demands for post-marketing surveillance.
The pharmacovigilance and drug safety software market is projected for substantial expansion over the coming years. This market is set to reach $4.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this anticipated growth during the forecast period encompass the proliferation of AI-driven signal detection, the rise in biologics and specialty drugs, intensified regulatory oversight, increased outsourcing of pharmacovigilance services, and the need for real-time safety analytics. Significant trends expected during this period include the wider acceptance of cloud-based pharmacovigilance platforms, a heightened emphasis on real-world evidence monitoring, greater automation in adverse event reporting, the extension of integrated drug safety systems, and a stronger demand for solutions ensuring regulatory compliance.
Get A Free Sample Report With In-Depth Market Insights:
Pharmacovigilance And Drug Safety Software Market Growth Factors: What’s Supporting Expansion?
The increasing need for personalized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market going forward. Personalized medicine, also referred to as precision medicine, is a healthcare approach that tailors treatment decisions to an individual’s genetic, biological, and lifestyle characteristics. The demand for personalized medicine is escalating due to improved treatment outcomes, more effective prevention and early detection strategies, and greater cost-effectiveness. The pharmacovigilance and drug safety software market supports personalized medicine by integrating pharmacogenetics, real-time data analytics, and post-marketing surveillance to optimize patient safety, monitor individualized treatments, and strengthen risk-management practices. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from 6 approvals in 2022. Therefore, the expanding demand for personalized medicine is fueling the growth of the pharmacovigilance and drug safety software market.
Pharmacovigilance And Drug Safety Software Market Segmentation And Category Overview
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
Pharmacovigilance And Drug Safety Software Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the pharmacovigilance and drug safety software market are strategically developing innovative technologies, such as cloud-based data lake platforms, to strengthen adverse event monitoring, improve regulatory compliance, and enhance overall patient safety across clinical trials and post-market surveillance activities. A cloud-based data lake platform is defined as a scalable, centralized system capable of storing and analyzing large volumes of both structured and unstructured safety data in real time, thereby enabling advanced analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched CorEvidence, a proprietary cloud-based data lake platform designed to optimize pharmacovigilance processes by improving safety data management and case processing efficiency, particularly supporting post-authorization safety studies within clinical research registries.
Pharmacovigilance And Drug Safety Software Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel
View The Full Pharmacovigilance And Drug Safety Software Market Report:
Pharmacovigilance And Drug Safety Software Market Top Region By Revenue And Market Share
North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Leave a Reply